Mauna Kea Technologies SAS Market Cap ($20.89 Million)
Market Cap & Net Worth: Mauna Kea Technologies SAS (ALMKT)
Mauna Kea Technologies SAS market cap. Mauna Kea Technologies SAS (PA:ALMKT) has a market capitalization of $20.89 Million (€17.87 Million) as of November 4, 2026. Listed on the PA stock exchange, this France-based company holds position #24801 globally and #399 in its home market, demonstrating a 1.09% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mauna Kea Technologies SAS's stock price €0.09 by its total outstanding shares 192097275 (192.10 Million). Also see ALMKT cash flow metrics for how efficiently the company converts equity into cash flow.
Mauna Kea Technologies SAS Market Cap History (2015–2026)
Mauna Kea Technologies SAS market cap history from 2015 to 2026. Data shows change from $689.47 Million to $20.89 Million (-25.76% CAGR). Check ALMKT live share price for real-time trading data and today's change.
Mauna Kea Technologies SAS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Mauna Kea Technologies SAS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Mauna Kea Technologies SAS (ALMKT) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
4.93x
Mauna Kea Technologies SAS's market cap is 4.93 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $689.47 Million | $8.55 Million | -$12.64 Million | 80.67x | N/A |
| 2016 | $678.24 Million | $8.79 Million | -$9.74 Million | 77.19x | N/A |
| 2017 | $1.06 Billion | $6.69 Million | -$10.24 Million | 159.19x | N/A |
| 2018 | $451.41 Million | $6.76 Million | -$13.22 Million | 66.78x | N/A |
| 2019 | $306.78 Million | $8.51 Million | -$15.27 Million | 36.05x | N/A |
| 2020 | $295.55 Million | $6.53 Million | -$12.79 Million | 45.29x | N/A |
| 2021 | $171.81 Million | $7.70 Million | -$13.45 Million | 22.31x | N/A |
| 2022 | $93.20 Million | $7.48 Million | -$11.18 Million | 12.46x | N/A |
| 2023 | $105.78 Million | $11.03 Million | -$3.73 Million | 9.59x | N/A |
| 2024 | $37.73 Million | $7.66 Million | -$10.40 Million | 4.93x | N/A |
Competitor Companies of ALMKT by Market Capitalization
Companies near Mauna Kea Technologies SAS in the global market cap rankings as of November 4, 2026. Also see Mauna Kea Technologies SAS balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Mauna Kea Technologies SAS by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $190.23 Billion | $109.40 |
| #204 | Stryker Corporation | NYSE:SYK | $119.12 Billion | $310.55 |
| #226 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $98.88 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Mauna Kea Technologies SAS (2015–2026)
Market capitalization of Mauna Kea Technologies SAS from 2015 to today. Between 2015 and today, Mauna Kea Technologies SAS's market cap moved from $689.47 Million to $ 20.89 Million, with a yearly change of -25.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €20.89 Million | +27.22% |
| 2025 | €16.42 Million | -56.49% |
| 2024 | €37.73 Million | -64.33% |
| 2023 | €105.78 Million | +13.49% |
| 2022 | €93.20 Million | -45.75% |
| 2021 | €171.81 Million | -41.87% |
| 2020 | €295.55 Million | -3.66% |
| 2019 | €306.78 Million | -32.04% |
| 2018 | €451.41 Million | -57.59% |
| 2017 | €1.06 Billion | +56.95% |
| 2016 | €678.24 Million | -1.63% |
| 2015 | €689.47 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Mauna Kea Technologies SAS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.89 Million USD |
| MoneyControl | $20.89 Million USD |
| MarketWatch | $20.89 Million USD |
| marketcap.company | $20.89 Million USD |
| Reuters | $20.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Mauna Kea Technologies SAS
Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate… Read more